DARIN DUTSON: Open Payments
NPI 1336713312 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 46 payments from 13 companies in 2025. Trend: 2023 $963 · 2024 $3,636 · 2025 $1,451
Food & beverage: $1,341Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $218 |
| Janssen Biotech, Inc. | 7 | $197 |
| Arcutis Biotherapeutics, Inc. | 6 | $181 |
| Galderma Laboratories, L.P. | 5 | $172 |
| GENZYME CORPORATION | 2 | $152 |
| PFIZER INC. | 9 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $85 |
| Novartis Pharmaceuticals Corporation | 1 | $53 |
| Amgen Inc. | 2 | $40 |
Products named: TREMFYA, Zoryve, NEMLUVIO, DUPIXENT, SPEVIGO, Sotyktu, CIBINQO, LITFULO.
Industry payments across NV — which companies pay providers there.
